Bbr Partners, LLC Crispr Therapeutics Ag Transaction History

Bbr Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$22.73 - $42.34 $113,650 - $211,700	-5,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$44.35 - $65.71 $133,050 - $197,129	-3,000 Reduced 37.5%	5,000 $222,000
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $127,859 - $220,770	3,000 Added 60.0%	8,000 $470,000
Q1 2018 May 10, 2018	BUY	$23.52 - $58.17 $117,600 - $290,850	5,000 New	5,000 $229,000

510

57.7M

1.74M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Bbr Partners, LLC with notifications on news.